Deferiprone Alternatives Compared
| Deferiprone | Exjade (deferasirox) | Hydroxyurea |
|
|---|
| Deferiprone | Exjade (deferasirox) | Hydroxyurea |
|
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Iron Overload, Superficial Siderosis, Thalassemia, Hemosiderosis. Deferiprone may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Iron Overload, Thalassemia, Hemosiderosis. Exjade may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Sickle Cell Anemia, Chronic Myelogenous Leukemia, Cervical Cancer, Glioblastoma Multiforme, Head and Neck Cancer, Plaque Psoriasis, Polycythemia Vera, Psoriasis, Psoriatic Arthritis... View more |
Related suggestions Thalassemia
|
|||||||||||||||
| More about Deferiprone | More about Exjade (deferasirox) | More about Hydroxyurea | ||||||||||||||||
| Ratings & Reviews | ||||||||||||||||||
|
Be the first to share your experience with this drug. |
Exjade has an average rating of 1.0 out of 10 from a total of 1 ratings on Drugs.com. 0% of reviewers reported a positive effect, while 100% reported a negative effect. |
Hydroxyurea has an average rating of 7.1 out of 10 from a total of 47 ratings on Drugs.com. 61% of reviewers reported a positive effect, while 22% reported a negative effect. |
||||||||||||||||
| Drug Class | ||||||||||||||||||
| Side Effects | ||||||||||||||||||
| Generic Availability | ||||||||||||||||||
|
N/A |
Lower cost generic |
|||||||||||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||||||||||
|
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Exjade prices |
View all Hydroxyurea prices |
||||||||||||||||
| Dosage Forms Available | ||||||||||||||||||
|
N/A |
|
|
||||||||||||||||
| Brand Names | ||||||||||||||||||
| Ferriprox | Other deferasirox brands include: Jadenu, Jadenu Sprinkle | Droxia, Hydrea, Siklos, Xromi | ||||||||||||||||
| Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||||||||||
|
1.9 hours |
16 hours |
4 hours |
||||||||||||||||
| CSA Schedule ** View glossary of terms | ||||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
| Pregnancy Category | ||||||||||||||||||
|
Category D
Positive evidence of risk
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category D
Positive evidence of risk
See the full pregnancy warnings document. |
||||||||||||||||
| Drug Interactions | ||||||||||||||||||
|
A total of 303 drugs are known to interact with Deferiprone:
|
A total of 596 drugs are known to interact with Exjade:
|
A total of 281 drugs are known to interact with Hydroxyurea:
|
||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||
| Disease Interactions | ||||||||||||||||||
| First Approval Date | ||||||||||||||||||
|
October 14, 2011 |
November 02, 2005 |
December 07, 1967 |
||||||||||||||||
| WADA Class View World Anti-Doping Agency classifications. | ||||||||||||||||||
|
N/A |
N/A |
N/A |
||||||||||||||||
| More Information | ||||||||||||||||||
| Patient resources | ||||||||||||||||||
| Professional Resources | ||||||||||||||||||
| Related Treatment Guide | ||||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.